Form 4: Invizyne Technologies Executive Sells Shares
Insider Transaction (Form 4)
Damien Alan Perriman, Chief Commercial Officer of Invizyne Technologies Inc, sold 3,729 shares of common stock on October 9, 2026 for $5.21 per share.
Summary
- Option exercise/conversion: acquired 3,922 Common Stock on October 9, 2026; holds 32,421 after (Direct).
- Open-market sale: disposed of 3,729 Common Stock at $5.21 ($19,427) on October 12, 2026; holds 28,692 after (Direct).
- Option exercise/conversion: disposed of 3,922 Restricted Stock Unit on October 9, 2026; holds 39,225 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $19,427 of stock on the open market.
Insider Transactions
Damien Alan Perriman — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-09 | Option exercise/conversion | Common Stock | 3,922 | — | — | 32,421 |
| 2026-10-12 | Open-market sale | Common Stock | 3,729 | $5 | $19.4K | 28,692 |
| 2026-10-09 | Option exercise/conversion | Restricted Stock Unit | 3,922 | — | — | 39,225 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-09 | Option exercise/conversion (3,922 shares) |
| 2026-10-12 | Open-market sale (3,729 shares) |
| 2026-10-09 | Option exercise/conversion (3,922 shares) |
Keywords
insider transaction, Form 4, EXOZ, EXOZYMES INC., bearish, Damien Alan Perriman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.